These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8372205)

  • 1. Positive bowel contrast agent for MR imaging of the abdomen: phase II and III clinical trials.
    Patten RM; Lo SK; Phillips JJ; Bowman SC; Glazer GM; Wall SD; Bova JG; Harris RD; Wheat RL; Johnson CD
    Radiology; 1993 Oct; 189(1):277-83. PubMed ID: 8372205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferric ammonium citrate as a positive bowel contrast agent for MR imaging of the upper abdomen. Safety and diagnostic efficacy.
    Kivelitz D; Gehl HB; Heuck A; Krahe T; Taupitz M; Lodemann KP; Hamm B
    Acta Radiol; 1999 Jul; 40(4):429-35. PubMed ID: 10394873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR enteroclysis using iron oxide particles (ferristene) as an endoluminal contrast agent: an open phase III trial.
    Boraschi P; Braccini G; Gigoni R; Cartei F; Perri G
    Magn Reson Imaging; 2004 Oct; 22(8):1085-95. PubMed ID: 15527995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent].
    Takahara T; Yoshikawa T; Saeki M; Nosaka S; Shimoyamada K; Nakajima Y; Ishikawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):425-6. PubMed ID: 7617470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MR imaging of colonic cancer with retrograde administration of contrast material containing ferric ammonium citrate].
    Mizuguchi M; Matsuo Y; Fukahori T; Kudo S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Dec; 55(15):1063-5. PubMed ID: 8587850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Optimization of dosage and exam technique in the use of oral contrast media in magnetic resonance].
    Broglia L; Tortora A; Maccioni F; Arpesani R; Marcelli G; Ascarelli A; Rossi P
    Radiol Med; 1999 May; 97(5):365-70. PubMed ID: 10432968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of suppression and visualization of the duodenal fluid in MR cholangiopancreatography using ferric ammonium citrate].
    Takahara T; Kurihara Y; Takahashi M; Nakajima Y; Ishikawa T
    Nihon Rinsho; 1998 Nov; 56(11):2865-9. PubMed ID: 9847611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
    Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
    Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MR imaging oral contrast agent mixed with milk for the small intestine].
    Hirohashi S; Hirohashi R; Uchida H; Kitano S; Tanaka M; Matsuo N; Ohishi H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Jul; 54(8):784-8. PubMed ID: 8072869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multisite phase III study of the safety and efficacy of a new manganese chloride-based gastrointestinal contrast agent for MRI of the abdomen and pelvis.
    Small WC; DeSimone-Macchi D; Parker JR; Sukerkar A; Hahn PF; Rubin DL; Zelch JV; Kuhlman JE; Outwater EK; Weinreb JC; Brown JJ; de Lange EE; Woodward PJ; Arildsen R; Foster GS; Runge VM; Aisen AM; Muroff LR; Thoeni RF; Parisky YR; Tanenbaum LN; Totterman S; Herfkens RJ; Knudsen J; Bernardino ME
    J Magn Reson Imaging; 1999 Jul; 10(1):15-24. PubMed ID: 10398973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of high concentration ferric ammonium citrate (FAC) solution as a negative bowel contrast agent: application in MR cholangiography].
    Takahara T; Saeki M; Nosaka S; Shimoyamada K; Suemitsu I; Nakajima Y; Yoshikawa T; Ishikawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Aug; 55(9):697-9. PubMed ID: 7478957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
    Low RN; Sigeti JS
    AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T2-weighted MR imaging of the upper part of the abdomen: should fat suppression be used routinely?
    Lu DS; Saini S; Hahn PF; Goldberg M; Lee MJ; Weissleder R; Gerard B; Halpern E; Cats A
    AJR Am J Roentgenol; 1994 May; 162(5):1095-100. PubMed ID: 8165989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
    Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
    Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging.
    Hahn PF; Stark DD; Lewis JM; Saini S; Elizondo G; Weissleder R; Fretz CJ; Ferrucci JT
    Radiology; 1990 Jun; 175(3):695-700. PubMed ID: 2343116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI.
    Hirohashi S; Uchida H; Yoshikawa K; Fujita N; Ohtomo K; Yuasa Y; Kawamura Y; Matsui O
    Magn Reson Imaging; 1994; 12(6):837-46. PubMed ID: 7968283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of oral contrast agents for abdominal magnetic resonance imaging.
    Kraus BB; Rappaport DC; Ros PR; Torres GM
    Magn Reson Imaging; 1994; 12(6):847-58. PubMed ID: 7968284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perflubron as an oral contrast agent for MR imaging: results of a phase III clinical trial.
    Mattrey RF; Trambert MA; Brown JJ; Young SW; Bruneton JN; Wesbey GE; Balsara ZN
    Radiology; 1994 Jun; 191(3):841-8. PubMed ID: 8184076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
    Yasumoto M; Shibuya H; Takeda M; Korenaga T
    AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.